BB-3497
BB-3497 is a potent, orally active and selective peptide deformylase (PDF) inhibitor. BB-3497 is highly selective for PDF (IC50 = 7 nM for E. coli PDF.Ni) over the other mammalian metalloenzymes (MMP-1/2/3/7 and enkephalinase). BB-3497 exhibits potent activity against gram-positive bacteria and some gram-negative pathogens. BB-3497 protects mice from infection in systemic models of Staphylococeus aureus. BB-3497 can be used for anti-bacterial infection research.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- CAS. Nr.: 235784-88-0
- Formel: C16H31N3O4
- Molecular Weight:329.44
-
Speicherung:
Please store the product under the recommended conditions in the Certificate of Analysis.
Alle Antibiotic Isoform-spezifische Produkte anzeigen
More
Biologische Aktivität
Beschreibung
In Vitro
BB-3497 binds to PDF such that the oxygen atoms of its N-formyl-hydroxylamine group occupy the positions of the two Ni-bound water molecules observed in the PDF-Met-Ala-Ser product complex[1].
BB-3497 shows superior in vitro antibacterial activity against E. coli DH5α and E. coli BL21(DE3) strains harboring a control plasmid (pET24) or pET24-PDF, with MIC values of 4, 8, 32, and 128 μg/mL, but shows an MIC of >128 μg/mL against an E. coli formyltransferase mutant, confirming that its antibacterial action is mediated through PDF inhibition[1].
BB-3497 (4-8x MIC, 24 h) results in <1-log-unit decreases in viable counts of S. aureus and E. coli, conforming its antibacterial effect[1].
BB-3497 (2-4x MIC, 24 h) results in resistant mutants at frequencies of 1 x 10-7 for E. coli and 2 x 10-7 for S. aureus, with high-level resistance conferred by mutations in the fmt gene and low-level resistance exhibited by mutants having a wild-type def-fmt operon[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
Parmacokinetics
| Species | Dose | Route | Cmax | AUC0-24 |
|---|---|---|---|---|
| Rat[1] | 100 mg/kg | p.o. | 24 mg/L | 34 mg·h/L |
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Male ICR-derived mice intraperitoneally inoculated with S. aureus[1]
-
Dosage:3, 6, 10, 30, 60 and 100 mg/kg
-
Administration:p.o. or i.v., single dose at 1 h after bacterial challenge
-
Result:Rescued mice from infection with an ED50 of 7 mg/kg (i.v.) and 8 mg/kg (p.o.), respectively.
-
Animal Model:Male ICR-derived mice intraperitoneally inoculated with methicillin-resistant S. aureus[1]
-
Dosage:3, 6, 10, 30, 60 and 100 mg/kg
-
Administration:p.o., single dose at 1 h after bacterial challenge
-
Result:Showed an ED50 of 14 mg/kg.
Chemical Information
-
CAS. Nr. 235784-88-0
-
Molecular Weight 329.44
-
Formel C16H31N3O4
-
SMILES
CCCC[C@@H](C(N[C@@H](C(C)(C)C)C(N(C)C)=O)=O)CN(O)C=O
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Please store the product under the recommended conditions in the Certificate of Analysis.
Protokoll
-
Research Protocol for Infectious Diseases
Infectious-disease experiments test how pathogens interact with host barriers, innate immune receptors, inflammatory signaling, pathogen replication, and tissue injury; pattern-recognition receptors such as TLRs, RIG-I-like receptors, NOD-like receptors, and inflammasomes detect microbial molecules and activate NF-κB, interferon, and cytokine responses. The central hypothesis is that infection severity reflects the balance between pathogen burden and host response: protective inflammation restricts pathogen growth, whereas excessive or mislocalized inflammation contributes to tissue damage and disease phenotype. Unresolved questions include which host pathways are protective versus pathogenic, why some infection models fail to translate to human disease, and which combined readouts best predict clinically relevant infection outcomes.
-
Mitochondrial membrane-potential fluorescent assay
Mitochondrial membrane potential fluorescent assays estimate ΔΨm in living cells using lipophilic cationic dyes such as TMRM, TMRE, rhodamine 123, and JC-1, which accumulate in mitochondria according to membrane polarization; loss of signal after FCCP or CCCP treatment is interpreted as mitochondrial depolarization. TMRM/TMRE and rhodamine 123 are commonly used for semi-quantitative live-cell microscopy or flow cytometry, while JC-1 can report a shift from red aggregate fluorescence to green monomer fluorescence during depolarization; interpretation requires controls because dye concentration, quenching mode, cell type, dye efflux, and mitochondrial mass can affect fluorescence independently of ΔΨm.
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
-
Mitochondrial membrane-potential and mitochondrial mass staining
Mitochondrial membrane potential staining measures the electrochemical polarization across the mitochondrial inner membrane in live cells using lipophilic cationic fluorescent probes; early rhodamine-based work showed that selective mitochondrial dye accumulation is lost when the mitochondrial transmembrane potential is dissipated. JC-1 reports mitochondrial polarization by shifting from green monomer fluorescence to red J-aggregate fluorescence as dye concentration increases within energized mitochondria; therefore, the red/green fluorescence ratio is used as a relative readout of mitochondrial membrane potential. TMRE or TMRM staining provides a single-channel relative readout because these cationic rhodamine esters accumulate in polarized mitochondria, and lower fluorescence indicates reduced mitochondrial polarization when acquisition and dye-loading conditions are controlled. Mitochondrial mass staining is commonly performed with MitoTracker Green FM or related MitoTracker dyes as
-
Gram Staining of Tissue Sections
Gram staining of tissue sections is a histochemical technique used to differentiate Gram-positive and Gram-negative bacteria within histological specimens based on differences in bacterial cell wall structure and dye retention, adapted from classical bacteriological Gram staining into tissue-compatible “histological Gram stain” variants. In tissue applications, modifications of the Brown-Hopps and Brown-Brenn methods are commonly used to improve differentiation of microorganisms embedded within host connective tissue and to reduce overstaining or loss of Gram-negative signal, which are known limitations of earlier approaches. The principle relies on crystal violet-iodine complex retention in Gram-positive organisms and subsequent decolorization and counterstaining steps that allow contrast visualization of Gram-negative organisms against tissue background.
Reinheit & Dokumentation
Verweise
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)